BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8888028)

  • 1. [Clinical effects of urokinase and sodium ozagrel in patients with acute symptomatic lacunar infarction].
    Sakamoto T; Harimoto K; Inoue S; Konishi A
    No To Shinkei; 1996 Sep; 48(9):805-9. PubMed ID: 8888028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical effects of sodium ozagrel and urokinase in patients with acute cerebral infarction in the territory of the internal carotid artery].
    Itoh H; Yamatani K; Oshida N; Shioi M; Takaba M; Kamiyama H; Itoh M
    No To Shinkei; 1998 Feb; 50(2):147-55. PubMed ID: 9513204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sodium ozagrel on hemostatic markers and cerebral blood flow in lacunar infarction.
    Oishi M; Mochizuki Y; Hara M; Yoshihashi H; Takasu T
    Clin Neuropharmacol; 1996 Dec; 19(6):526-31. PubMed ID: 8937792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ozagrel, a selective thromboxane A2-synthetase inhibitor, on cerebral infarction in rats. Comparative study with norphenazone, a free-radical scavenger.
    Imamura T; Kiguchi S; Kobayashi K; Ichikawa K; Yamazaki Y; Kojima M
    Arzneimittelforschung; 2003; 53(10):688-94. PubMed ID: 14650360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of ozagrel sodium on photochemical thrombosis in rat: therapeutic window and combined therapy with heparin sodium.
    Arii K; Igarashi H; Arii T; Katayama Y
    Life Sci; 2002 Nov; 71(25):2983-94. PubMed ID: 12384182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study on ultra-early intravenous thrombolysis with high-dose urokinase in treatment of acute cerebral infarction].
    Shi Y; Li D; Zhao Y
    Zhonghua Yi Xue Za Zhi; 2000 Feb; 80(2):101-3. PubMed ID: 11798744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical effect of combination therapy with edaravone and sodium ozagrel for acute cerebral infarction].
    Takabatake Y; Uno E; Wakamatsu K; Yamazaki N; Hashimoto N; Tsuchiya Y
    No To Shinkei; 2003 Jul; 55(7):589-93. PubMed ID: 12910992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sodium ozagrel].
    Kitagawa Y
    Nihon Rinsho; 2006 Oct; 64 Suppl 7():554-61. PubMed ID: 17461205
    [No Abstract]   [Full Text] [Related]  

  • 10. Ozagrel for Patients With Noncardioembolic Ischemic Stroke: A Propensity Score-Matched Analysis.
    Wada T; Yasunaga H; Horiguchi H; Fushimi K; Matsubara T; Nakajima S; Yahagi N
    J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2828-2837. PubMed ID: 27567296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical thrombolysis with adjuvant intraarterial urokinase for treatment of hyperacute ischemic stroke patients.
    Tikkakoski T
    Acta Radiol; 2008 Apr; 49(3):249. PubMed ID: 18365806
    [No Abstract]   [Full Text] [Related]  

  • 12. Intra-arterial thrombolysis in acute ischaemic stroke.
    Jones MM; Nogajski JH; Faulder K; Harrington T; Ng P; Storey CE
    Intern Med J; 2005 May; 35(5):300-2. PubMed ID: 15845114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A double-blind comparative study of intracoronary administration of GE-0943 and urokinase: multicenter study].
    Kambara H; Kawai C; Kajiwara N; Kammatsuse K; Nitani H; Sasayama S; Kodama K; Sato H; Nobuyoshi M; Nakashima M
    Kokyu To Junkan; 1989 Jul; 37(7):749-56. PubMed ID: 2678331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombolysis of cerebral thromboembolism by urokinase in an animal model].
    Hirschberg M; Korves M; Koc I; Hofferberth B; Wiesmann W
    Schweiz Med Wochenschr; 1987 Nov; 117(46):1811-3. PubMed ID: 3423767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of thrombolysis.
    Sell JJ; Rupp FW; Telepak RJ
    West J Med; 1996; 165(1-2):53. PubMed ID: 8855686
    [No Abstract]   [Full Text] [Related]  

  • 16. [New methods of intensive therapy in stroke: hemicraniectomy in patients with complete middle cerebral artery infarction and treatment of intracerebral and intraventricular hemorrhage with urokinase].
    Kakuk I; Major O; Gubucz I; Nyáry I; Nagy Z
    Ideggyogy Sz; 2002 Mar; 55(3-4):118-27. PubMed ID: 12122981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of a thromboxane-synthetase inhibitor in patients with chronic persistent coughing and no airwayhyperresponsiveness].
    Nishi K; Mizuguchi M; Tachibana H; Watanabe K; Ooka T; Fujimura M; Matsuda T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Sep; 35(9):927-33. PubMed ID: 9396248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of combination therapy with disodium cromoglycate (DSCG) and Ozagrel on non-atopic asthmatics].
    Yoshida N; Suguro H; Hashimoto N; Majima T; Yamaguchi M; Horie T
    Arerugi; 1994 Oct; 43(10):1262-9. PubMed ID: 7826222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of the thrombolytic efficacy of single-chain urokinase (Pro-urokinase) by heparin.
    Gulba DC; Fischer K; Reil GH; Daniel WG; Lichtlen PR
    Thromb Haemost; 1988 Oct; 60(2):350-1. PubMed ID: 3146150
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of different start time of urokinase therapy after acute myocardial infarction efficacy of thrombolysis. The Collaborative Research Group on Thrombolysis.
    Chin Med J (Engl); 1997 Jan; 110(1):47-9. PubMed ID: 9594321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.